Fufeng Group Limited
0.51
EUR
+0.04
(+8.05%)
ISIN
KYG368441195
CUSIP
G36844119
Return %
Stock
S&P 500
1Y
-48.48
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
CNY
•
in mil. unless spec.Working Capital
CNY
•
in mil. unless spec.Growth Rates
CNY
•
in mil. unless spec.Semi-annual Revenue
CNY
•
in mil. unless spec.Semi-annual Earnings Per Share
CNY
•
in mil. unless spec.Semi-annual Dividends Per Share
CNY
•
in mil. unless spec.Company Description
- CEO
- Deheng Li
- Full Time Employees
- 17,000
- Sector
- Consumer non-durables
- Industry
- Food: specialty/candy
- Address
- Building 4 Qingdao SD China 266114
- IPO Date
- Feb 8, 2007
- Website
- fufeng-group.com
- Similar Companies
- Business
- Fufeng Group Limited, founded in 1999 and headquartered in Qingdao, China, is a leading manufacturer and supplier of biochemical fermentation products specializing in food additives, animal nutrition, high-end amino acids, and colloids. The company’s core product portfolio includes monosodium glutamate (MSG), xanthan gum, gellan gum, glutamic acid, starch sweeteners such as glucose and fructose, compound seasonings, corn oil, amino acids including threonine, lysine, L-valine, and isoleucine, as well as bio-fermentation fertilizers and chicken bouillon. Additionally, Fufeng produces healthcare products like cordycepin capsules and animal health supplements. The company sells its products domestically in China and exports to over 120 countries across North America, South America, Central Asia, Europe, and Russia, supported by five production plants in China and multiple overseas marketing centers. Fufeng Group operates through several business segments: Food Additives, Animal Nutrition, High-End Amino Acid, Colloid, and Others. The Food Additives segment features fermentation products like MSG, starch sweeteners, and compound seasonings. Animal Nutrition offers refined corn products and amino acids aimed at animal feed markets. The High-End Amino Acid segment focuses on specialty amino acids, while the Colloid segment provides xanthan gum and gellan gum products utilized in food, pharmaceuticals, and other industries. The Other segment encompasses fertilizers, synthetic ammonia, autoclaved aerated concrete blocks, pharmaceuticals, cosmetics, biological products, and logistics services. Fufeng's products are widely applied in food production, animal husbandry, healthcare, pharmaceuticals, and petroleum exploration industries. Recent major developments for Fufeng Group include the signing of a new export contract with a leading beverage manufacturer for amino acid supplies, enhancing its international sales outlook. The company also completed an equity buyback program in late 2023, repurchasing over 16 million shares. In 2025, Fufeng reported a strong financial performance with attributable profit increasing by over 70% year-on-year in interim results, reflecting robust demand and operational improvements. The company continues expanding its international footprint with overseas representative offices in key regions and pursuing strategic initiatives to enhance its product quality and global competitiveness amid ongoing trade challenges. The Group maintains a focus on diversification and high-value biochemical fermentation products as part of its long-term sustainable growth strategy. Fufeng Group is recognized as the world’s largest producer of MSG and xanthan gum, solidifying its leadership in the biochemical fermentation industry. The Group's extensive product range, global customer base, and continuous innovation position it as a major player in the global food additives and biochemical fermentation markets. It remains committed to scaling its international operations and diversifying its product offerings through research and development and strategic market expansion. Overall, Fufeng Group Limited is a diversified biochemical fermentation company with a broad product portfolio across food additives, animal nutrition, amino acids, and colloids, serving a global market. Recent contract wins, strong financial results, and share repurchases underscore its operational strength and strategic focus on international growth and product innovation. The company's operations span China and over 120 export markets with significant production capabilities and marketing infrastructure worldwide.